Literature DB >> 24491801

UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells.

Jae-Hwan Kim1, Amrish Sharma, Shilpa S Dhar, Sung-Hun Lee, Bingnan Gu, Chia-Hsin Chan, Hui-Kuan Lin, Min Gyu Lee.   

Abstract

Histone methyltransferases and demethylases reversibly modulate histone lysine methylation, which is considered a key epigenetic mark associated with gene regulation. Recently, aberrant regulation of gene expression by histone methylation modifiers has emerged as an important mechanism for tumorigenesis. However, it remains largely unknown how histone methyltransferases and demethylases coregulate transcriptional profiles for cancer cell characteristics. Here, we show that in breast cancer cells, the histone H3 lysine 27 (H3K27) demethylase UTX (also known as KDM6A) positively regulates gene expression programs associated with cell proliferation and invasion. The majority of UTX-controlled genes, including a cohort of oncogenes and prometastatic genes, are coregulated by the H3K4 methyltransferase mixed lineage leukemia 4 (MLL4, also called ALR, KMT2D, and MLL2). UTX interacted with a C-terminal region of MLL4. UTX knockdown resulted in significant decreases in the proliferation and invasiveness of breast cancer cells in vitro and in a mouse xenograft model. Such defective cellular characteristics of UTX-depleted cells were phenocopied by MLL4 knockdown cells. UTX-catalyzed demethylation of trimethylated H3K27 and MLL4-mediated trimethylation at H3K4 occurred interdependently at cotarget genes of UTX and MLL4. Clinically, high levels of UTX or MLL4 were associated with poor prognosis in patients with breast cancer. Taken together, these findings uncover that coordinated regulation of gene expression programs by a histone methyltransferase and a histone demethylase is coupled to the proliferation and invasion of breast cancer cells. ©2014 AACR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24491801      PMCID: PMC3962500          DOI: 10.1158/0008-5472.CAN-13-1896

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

Review 1.  The diverse functions of histone lysine methylation.

Authors:  Cyrus Martin; Yi Zhang
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

2.  Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues.

Authors:  Lei Ding; Christine Erdmann; Arul M Chinnaiyan; Sofia D Merajver; Celina G Kleer
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

3.  Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth.

Authors:  Irina Issaeva; Yulia Zonis; Tanya Rozovskaia; Kira Orlovsky; Carlo M Croce; Tatsuya Nakamura; Alex Mazo; Lea Eisenbach; Eli Canaani
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

4.  High-resolution profiling of histone methylations in the human genome.

Authors:  Artem Barski; Suresh Cuddapah; Kairong Cui; Tae-Young Roh; Dustin E Schones; Zhibin Wang; Gang Wei; Iouri Chepelev; Keji Zhao
Journal:  Cell       Date:  2007-05-18       Impact factor: 41.582

5.  PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.

Authors:  Young-Wook Cho; Teresa Hong; Sunhwa Hong; Hong Guo; Hong Yu; Doyeob Kim; Tad Guszczynski; Gregory R Dressler; Terry D Copeland; Markus Kalkum; Kai Ge
Journal:  J Biol Chem       Date:  2007-05-11       Impact factor: 5.157

Review 6.  Regulation of histone methylation by demethylimination and demethylation.

Authors:  Robert J Klose; Yi Zhang
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03-07       Impact factor: 94.444

Review 7.  Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark.

Authors:  Alexander J Ruthenburg; C David Allis; Joanna Wysocka
Journal:  Mol Cell       Date:  2007-01-12       Impact factor: 17.970

8.  Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination.

Authors:  Min Gyu Lee; Raffaella Villa; Patrick Trojer; Jessica Norman; Kai-Ping Yan; Danny Reinberg; Luciano Di Croce; Ramin Shiekhattar
Journal:  Science       Date:  2007-08-30       Impact factor: 47.728

9.  Genome-wide maps of chromatin state in pluripotent and lineage-committed cells.

Authors:  Tarjei S Mikkelsen; Manching Ku; David B Jaffe; Biju Issac; Erez Lieberman; Georgia Giannoukos; Pablo Alvarez; William Brockman; Tae-Kyung Kim; Richard P Koche; William Lee; Eric Mendenhall; Aisling O'Donovan; Aviva Presser; Carsten Russ; Xiaohui Xie; Alexander Meissner; Marius Wernig; Rudolf Jaenisch; Chad Nusbaum; Eric S Lander; Bradley E Bernstein
Journal:  Nature       Date:  2007-07-01       Impact factor: 49.962

10.  The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells.

Authors:  Adrian P Bracken; Daniela Kleine-Kohlbrecher; Nikolaj Dietrich; Diego Pasini; Gaetano Gargiulo; Chantal Beekman; Kim Theilgaard-Mönch; Saverio Minucci; Bo T Porse; Jean-Christophe Marine; Klaus H Hansen; Kristian Helin
Journal:  Genes Dev       Date:  2007-03-01       Impact factor: 11.361

View more
  98 in total

Review 1.  Epigenetic regulation of epithelial-mesenchymal transition.

Authors:  Lidong Sun; Jia Fang
Journal:  Cell Mol Life Sci       Date:  2016-07-08       Impact factor: 9.261

Review 2.  MLL3/MLL4/COMPASS Family on Epigenetic Regulation of Enhancer Function and Cancer.

Authors:  Christie C Sze; Ali Shilatifard
Journal:  Cold Spring Harb Perspect Med       Date:  2016-11-01       Impact factor: 6.915

3.  ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis.

Authors:  Yan Chen; Bo Zhang; Lei Bao; Lai Jin; Mingming Yang; Yan Peng; Ashwani Kumar; Jennifer E Wang; Chenliang Wang; Xuan Zou; Chao Xing; Yingfei Wang; Weibo Luo
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

Review 4.  Molecular pathways: deregulation of histone h3 lysine 27 methylation in cancer-different paths, same destination.

Authors:  Teresa Ezponda; Jonathan D Licht
Journal:  Clin Cancer Res       Date:  2014-07-01       Impact factor: 12.531

Review 5.  Hijacked in cancer: the KMT2 (MLL) family of methyltransferases.

Authors:  Rajesh C Rao; Yali Dou
Journal:  Nat Rev Cancer       Date:  2015-06       Impact factor: 60.716

Review 6.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

7.  A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription.

Authors:  Shu-Ping Wang; Zhanyun Tang; Chun-Wei Chen; Miho Shimada; Richard P Koche; Lan-Hsin Wang; Tomoyoshi Nakadai; Alan Chramiec; Andrei V Krivtsov; Scott A Armstrong; Robert G Roeder
Journal:  Mol Cell       Date:  2017-07-20       Impact factor: 17.970

Review 8.  Enhancer deregulation in cancer and other diseases.

Authors:  Hans-Martin Herz
Journal:  Bioessays       Date:  2016-08-29       Impact factor: 4.345

9.  A comparative analysis of KMT2D missense variants in Kabuki syndrome, cancers and the general population.

Authors:  Víctor Faundes; Geraldine Malone; William G Newman; Siddharth Banka
Journal:  J Hum Genet       Date:  2018-11-20       Impact factor: 3.172

Review 10.  H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer.

Authors:  J N Nichol; D Dupéré-Richer; T Ezponda; J D Licht; W H Miller
Journal:  Adv Cancer Res       Date:  2016-06-17       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.